 |
ASCO Annual meeting 2019 May 31st – June 4th 2019 McCormick Place, Chicago, Illinois, USA |
Invectys will be attending the 2019 ASCO Annual Meeting, where we will present our poster “Final results of a First-in-Human Phase I Study evaluating INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors”.
ASCO offers a robust program designed to teach, engage, and bring the oncology field together. In addition to presenting the latest research in cancer care, the program will feature world-renowned faculty discussing state-of-the-art treatment modalities, new therapies, and ongoing controversies in the field.
If you would like to set up a meeting, feel free to contact us at contact@invectys.com.